CTOs on the Move

Vanguard Advanced Pharmacy Systems Inc

www.vanguardrx.com

 
Vanguard Advanced Pharmacy Systems Inc is a Bradenton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Pro Med Kits

Pro Med Kits is a Davis, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

I.T.S. IMPLANTAT-TECHNOLOGIE-SYSTEMS

I.T.S. IMPLANTAT-TECHNOLOGIE-SYSTEMS is a Prior Lake, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tempo Wholesale Medical

Tempo Wholesale Medical Llc is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Immucor

For more than 30 years, Immucor has been a proud partner to thousands of hospitals, reference laboratories and donor centers. We remain focused on continuing to innovate as we work to advance the science of transfusion and transplantation diagnostics. We are guided by our corporate Mission and Values. We strive to create a world where anyone, anywhere in need of blood or an organ gets the right blood or organ that is safe, accessible and affordable. We will be guided by our Core Values of Respect, Integrity, Teamwork and Achievement. In doing so, we will: • strive to achieve the highest quality products and solutions; • bring forth and pursue innovations that advance patient safety; • honor our customers with the highest level of service.

Glaukos

Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.